-
1
-
-
0032892343
-
Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - A review of preclinical data
-
DOI 10.1016/S0028-3908(99)00019-2, PII S0028390899000192
-
CG Parsons W Danysz G Quack 1999 Neuropharmacology 38 735 767 10.1016/S0028-3908(99)00019-2 10.1016/S0028-3908(99)00019-2 1:CAS:528: DyaK1MXjslGjsbY%3D (Pubitemid 29187336)
-
(1999)
Neuropharmacology
, vol.38
, Issue.6
, pp. 735-767
-
-
Parsons, C.G.1
Danysz, W.2
Quack, G.3
-
4
-
-
0025871272
-
-
1:STN:280:DyaK387ktlylsA%3D%3D
-
K Ditzler 1991 Arzneim-Forsch 41 773 780 1:STN:280:DyaK387ktlylsA%3D%3D
-
(1991)
Arzneim-Forsch
, vol.41
, pp. 773-780
-
-
Ditzler, K.1
-
7
-
-
30344477961
-
Pharmacokinetic study of memantine in healthy and renally impaired subjects
-
DOI 10.1016/j.clpt.2005.10.005, PII S0009923605004649
-
A Periclou D Ventura N Rao W Abramowitz 2006 Clin Pharmacol Ther 79 134 143 10.1016/j.clpt.2005.10.005 10.1016/j.clpt.2005.10.005 1:CAS:528: DC%2BD28XksVGlug%3D%3D (Pubitemid 43069584)
-
(2006)
Clinical Pharmacology and Therapeutics
, vol.79
, Issue.1
, pp. 134-143
-
-
Periclou, A.1
Ventura, D.2
Rao, N.3
Abramowitz, W.4
-
9
-
-
0029085113
-
-
10.1016/0304-3940(95)11785-U 10.1016/0304-3940(95)11785-U 1:CAS:528:DyaK2MXntl2lsrw%3D
-
J Kornhuber G Quack 1995 Neurosci Lett 195 137 139 10.1016/0304-3940(95) 11785-U 10.1016/0304-3940(95)11785-U 1:CAS:528:DyaK2MXntl2lsrw%3D
-
(1995)
Neurosci Lett
, vol.195
, pp. 137-139
-
-
Kornhuber, J.1
Quack, G.2
-
12
-
-
0036258669
-
Quantitative analysis of memantine in human plasma by gas chromatography/negative ion chemical ionization/mass spectrometry
-
DOI 10.1002/jms.303
-
HJ Leis G Fauler W Windischhofer 2002 J Mass Spectrom 37 477 480 10.1002/jms.303 10.1002/jms.303 1:CAS:528:DC%2BD38XktlSrsbo%3D (Pubitemid 34578389)
-
(2002)
Journal of Mass Spectrometry
, vol.37
, Issue.5
, pp. 477-480
-
-
Leis, H.J.1
Fauler, G.2
Windischhofer, W.3
-
14
-
-
0035950827
-
Separation methods for tricyclic antiviral drugs
-
DOI 10.1016/S0378-4347(01)00318-8, PII S0378434701003188
-
RF Suckow 2001 J Chromatogr B Biomed Sci Appl 764 313 325 10.1016/S0378-4347(01)00318-8 10.1016/S0378-4347(01)00318-8 1:CAS:528: DC%2BD3MXot1Ohtb8%3D (Pubitemid 33044671)
-
(2001)
Journal of Chromatography B: Biomedical Sciences and Applications
, vol.764
, Issue.1-2
, pp. 313-325
-
-
Suckow, R.F.1
-
15
-
-
0027186182
-
Direct determination of adamantanamine in plasma and urine with automated solid phase derivatization
-
DOI 10.1016/0378-4347(93)80450-I
-
FX Zhou IS Krull B Feibush 1993 J Chromatogr A 619 93 101 10.1016/0378-4347(93)80450-I 10.1016/0378-4347(93)80450-I 1:CAS:528: DyaK3sXms1Wqs70%3D (Pubitemid 23282011)
-
(1993)
Journal of Chromatography - Biomedical Applications
, vol.619
, Issue.1
, pp. 93-101
-
-
Zhou, F.-X.1
Krull, I.S.2
Feibush, B.3
-
16
-
-
0036178645
-
Electrophoretic behavior of adamantane derivatives possessing antiviral activity and their determination by capillary zone electrophoresis with indirect detection
-
DOI 10.1002/1522-2683(200202)23:2<259::AID-ELPS259>3.0.CO;2-U
-
N Reichova J Pazourek P Polaskova J Havel 2002 Electrophoresis 23 259 262 10.1002/1522-2683(200202)23:2<259::AID-ELPS259>3.0.CO;2-U 10.1002/1522-2683(200202)23:2<259::AID-ELPS259>3.0.CO;2-U 1:CAS:528:DC%2BD38XhtlajtLs%3D (Pubitemid 34157093)
-
(2002)
Electrophoresis
, vol.23
, Issue.2
, pp. 259-262
-
-
Reichova, N.1
Pazourek, J.2
Polakova, P.3
Havel, J.4
-
18
-
-
43549083886
-
Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry
-
DOI 10.1016/j.clinthera.2008.04.005, PII S0149291808001446
-
MY Liu SN Meng HZ Wu S Wang MJ Wei 2008 J Clin Ther 30 641 653 10.1016/j.clinthera.2008.04.005 10.1016/j.clinthera.2008.04.005 1:CAS:528:DC%2BD1cXhtVWltLnE (Pubitemid 351680492)
-
(2008)
Clinical Therapeutics
, vol.30
, Issue.4
, pp. 641-653
-
-
Liu, M.-Y.1
Meng, S.-N.2
Wu, H.-Z.3
Wang, S.4
Wei, M.-J.5
-
19
-
-
33947365470
-
Determination of memantine in human plasma by liquid chromatography- electrospray tandem mass spectrometry: Application to a bioequivalence study
-
DOI 10.1016/j.jchromb.2006.10.045, PII S1570023206008634
-
AA Almeida DR Campos G Bernascone S Calafatti FAP Barros MN Eberlin EC Meurer EG Paris J Pedrazzoli 2007 J Chromatogr B Analyt Technol Biomed Life Sci 848 311 316 10.1016/j.jchromb.2006.10.045 10.1016/j.jchromb.2006.10.045 1:CAS:528:DC%2BD2sXjsVWjtbs%3D (Pubitemid 46453301)
-
(2007)
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
, vol.848
, Issue.2
, pp. 311-316
-
-
Almeida, A.A.1
Campos, D.R.2
Bernasconi, G.3
Calafatti, S.4
Barros, F.A.P.5
Eberlin, M.N.6
Meurer, E.C.7
Paris, E.G.8
Pedrazzoli, J.9
-
20
-
-
0003484310
-
-
Food and Drug Administration Center for Drug Evaluation and Research (CDER) US Department of Health and Human Services
-
Food and Drug Administration Center for Drug Evaluation and Research (CDER) Guidance for Industry, Bioanalytical Method Validation (2001) US Department of Health and Human Services
-
(2001)
Guidance for Industry, Bioanalytical Method Validation
-
-
-
21
-
-
0037663202
-
Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS
-
DOI 10.1021/ac020361s
-
BK Matuszewski ML Constanzer CM Chavez-Eng 2003 Anal Chem 75 3019 3030 10.1021/ac020361s 10.1021/ac020361s 1:CAS:528:DC%2BD3sXltV2jsL8%3D (Pubitemid 36830428)
-
(2003)
Analytical Chemistry
, vol.75
, Issue.13
, pp. 3019-3030
-
-
Matuszewski, B.K.1
Constanzer, M.L.2
Chavez-Eng, C.M.3
|